Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, Ohio.
Department of Otolaryngology, Harvard Medical School; Massachusetts Eye and Ear, Boston, Massachusetts, U.S.A.
Laryngoscope. 2019 Sep;129(9):2094-2104. doi: 10.1002/lary.27814. Epub 2019 Jan 22.
To investigate the frequency and outcomes of elective neck dissection (END) for adenoid cystic carcinoma (ACC) of the head and neck.
The National Cancer Database was queried for a cohort study of patients with ACC of the major salivary glands, nasal cavity/nasopharynx, hard/soft palate, tongue, floor of mouth, larynx, and oral cavity who underwent primary surgical resection from 2004 to 2014. Multivariable logistic regression was used to identify predictors of END and occult nodal metastasis. Overall survival (OS) was estimated using the Kaplan-Meier method and modeled with Cox proportional hazards regression.
Among 2,807 patients with ACC treated surgically, 636 (22.7%) underwent END. Patients with ACC of the salivary glands and tongue most frequently underwent END; patients with hard/soft palate (odds ratio [OR] 0.06, P < 0.001) and nasal cavity/nasopharynx (OR 0.05, P < 0.001) ACC rarely underwent END compared to patients with major salivary gland cancer. Increasing tumor (T) stage (T4 vs. T1, OR 3.02, P < 0.001) was associated with END. Patients with advanced T3 to T4 ACC of the major salivary glands demonstrated extended OS associated with END (5-year OS 78.1% vs. 70.4%, P = 0.041) on Kaplan-Meier analysis and with END with adjuvant radiation therapy (hazard ratio 0.55, P = 0.027) using Cox proportional hazards regression. Elective neck dissection for T4 ACC of the salivary glands (21.3%) and tongue (25.5%) most consistently revealed occult nodal metastasis.
Elective neck dissection for ACC of the major salivary glands or tongue is most likely to reveal occult nodal metastasis. Elective neck dissection is associated with extended OS for advanced-stage ACC of the major salivary glands.
NA Laryngoscope, 129:2094-2104, 2019.
研究头颈部腺样囊性癌(ACC)选择性颈清扫术(END)的频率和结局。
本研究通过国家癌症数据库,对 2004 年至 2014 年间接受原发手术切除的大涎腺、鼻腔/鼻咽、硬/软腭、舌、口底、喉和口腔的 ACC 患者进行队列研究。多变量逻辑回归用于确定 END 和隐匿性淋巴结转移的预测因素。使用 Kaplan-Meier 方法估计总生存率(OS),并使用 Cox 比例风险回归模型进行建模。
在 2807 例接受手术治疗的 ACC 患者中,有 636 例(22.7%)接受了 END。ACC 发生于涎腺和舌的患者最常接受 END;与大涎腺癌患者相比,发生于硬/软腭(比值比[OR]0.06,P<0.001)和鼻腔/鼻咽(OR0.05,P<0.001)的 ACC 患者很少接受 END。肿瘤(T)分期增加(T4 与 T1,OR3.02,P<0.001)与 END 相关。在 Kaplan-Meier 分析中,大涎腺 T3 至 T4 期 ACC 患者接受 END 治疗后显示出延长的 OS(5 年 OS 78.1%比 70.4%,P=0.041),并在 Cox 比例风险回归中,接受 END 加辅助放疗的患者(风险比 0.55,P=0.027)显示出延长的 OS。选择性颈清扫术用于治疗涎腺(21.3%)和舌(25.5%)的 T4 期 ACC 最有可能发现隐匿性淋巴结转移。
大涎腺或舌的 ACC 选择性颈清扫术最有可能发现隐匿性淋巴结转移。对于大涎腺的晚期 ACC,选择性颈清扫术与延长的 OS 相关。
无。喉科学,129:2094-2104,2019。